Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | CCT129254 |
Synonyms | |
Therapy Description |
CCT129254 is a small molecule ATP-competitive inhibitor of AKT and Rho kinases, which results in decreased tumor cell migration and metastasis (PMID: 25840982). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
CCT129254 | AT11854 | AKT Inhibitor (Pan) - ATP competitive 7 | CCT129254 is a small molecule ATP-competitive inhibitor of AKT and Rho kinases, which results in decreased tumor cell migration and metastasis (PMID: 25840982). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|